Even more confidence is obtained from the direct observation of RD2-eliminating Aβ oligomers from APP/PS1 mouse brain homogenate ex vivo (Figure 3) and from AD patient-derived brain homogenate (Figures 4 and 5). This evidence concerns the gene APP and Alzheimer disease.